关注
Jiyeon Kim
Jiyeon Kim
未知所在单位机构
在 bridgebiorx.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Efficient and stereoselective syntheses of DAB-1 and d-fagomine via chiral 1, 3-oxazine
JY Kim, Y Mu, X Jin, SH Park, VT Pham, DK Song, KY Lee, WH Ham
Tetrahedron 67 (48), 9426-9432, 2011
452011
1, 3-Oxazine as a chiral building block used in the total synthesis of (+)-1-deoxynojirimycin and (2R, 5R)-dihydroxymethyl-(3R, 4R)-dihydroxypyrrolidine
SH Park, JY Kim, JS Kim, C Jung, DK Song, WH Ham
Tetrahedron: Asymmetry 26 (12-13), 657-661, 2015
272015
Total synthesis of D-lyxo-phytosphingosine and formal synthesis of pachastrissamine via a chiral 1, 3-oxazine
Y Mu, JY Kim, X Jin, SH Park, JE Joo, WH Ham
Synthesis 44 (15), 2340-2346, 2012
252012
Asymmetric total syntheses of (+)-2, 5-dideoxy-2, 5-imino-d-glucitol [(+)-DGDP] and (−)-1-deoxymannojirimycin [(−)-DMJ] via an extended chiral 1, 3-oxazine
IS Myeong, C Jung, JY Kim, SH Park, WH Ham
Tetrahedron Letters 59 (25), 2422-2425, 2018
72018
Imidazopyrimidine and imidazotriazine derivative, and pharmaceutical composition comprising the same
CE Park, YK Jang, YJ Shin, JY Kim, SM Ham, HK Min, SB CHA, HJ JUNG, ...
US Patent 10,100,057, 2018
12018
Imidazopyrimidine and imidazotriazine derivative, and pharmaceutical composition comprising the same
CE Park, YK Jang, YJ Shin, JY Kim, SM Ham, HK Min, SB CHA, HJ JUNG, ...
US Patent 9,745,310, 2017
12017
Compound for targeted protein degradation, and use thereof
JYK WS Han, JW Nam, DH Ki, EJ Kim, HM Choi, CW Kim
WO Patent WO2024072178A1, 2024
2024
Imidazopyrimidine and imidazotriazine derivative, and pharmaceutical composition comprising the same
CE Park, YK Jang, YJ Shin, JY Kim, SM Ham, HK Min, SB CHA, HJ JUNG, ...
US Patent 11,046,702, 2021
2021
Imidazopyrimidine and imidazotriazine derivative, and pharmaceutical composition comprising the same
CE Park, YK Jang, YJ Shin, JY Kim, SM Ham, HK Min, SB CHA, HJ JUNG, ...
US Patent App. 16/146,644, 2019
2019
系统目前无法执行此操作,请稍后再试。
文章 1–9